Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 30;9(4):1834-1840.
doi: 10.4103/jfmpc.jfmpc_1037_19. eCollection 2020 Apr.

Non-Hodgkin's lymphoma: A review

Rohit Singh  1 , Shabana Shaik  2 , Bhupender Singh Negi  3 , Jagadish Prasad Rajguru  4 , Pankaj Bajirao Patil  5 , Anuj Singh Parihar  6 , Uma Sharma  7
Affiliations
Review

Non-Hodgkin's lymphoma: A review

Rohit Singh et al. J Family Med Prim Care. .

Abstract

Lymphomas constitute the third most common neoplasm in head and neck region arising from the lymphoreticular system. Malignant lymphomas are divided into Hodgkin's disease and non-Hodgkin's lymphoma (NHL). NHL comprises approximately 5% of head and neck malignancies and displays a wide range of appearances comparable with Hodgkin's disease. Hodgkin's and non-Hodgkin's lymphomas are seen in the head and neck region, but extranodal disease, with or without lymph node involvement, is more common among NHL patients. Extranodal involvement includes the areas such as Waldeyer's ring (i.e., the tonsils, pharynx, and base of the tongue), salivary glands, orbit, paranasal sinuses, and thyroid glands. There are several classification systems for categorizing NHL out of which WHO classification for lymphoid neoplasms is mostly followed. This review describes the pathogenesis of NHL and explains some of the important NHL (Marginal zone B-cell Lymphoma, follicular lymphoma, mantle cell lymphoma).

Keywords: Cell; Non Hodgkin's lymphoma; lymphomas.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Rajendran R, Sivapathasundharam B, editors. Shafers Textbook of Oral Pathology. 6th ed. Elsevier; 2009. Benign and malignant tumors of oral cavity; pp. 173–8.
    1. Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Non-Hodgkin lymphoma. BMJ. 2018;362:k3204. - PubMed
    1. Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma-A review. Acta Oncol. 2006;45:258–71. - PubMed
    1. Kolokotronis A, Konstantinou N, Christakis I, Papadimitriou P, Matiakis A, Zaraboukas T, et al. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: A clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:303–10. - PubMed
    1. Yok-Lam Kwong. Predicting the outcome in non-Hodgkin lymphoma with molecular markers. British Journal of Haematology. 2007;137:273–87. - PubMed